NCT04136561

Brief Summary

The goal of this study is to determine if early placement of a midline catheter in patients with a central venous catheter (CVC) will decrease the number of days the CVC is in place. Patients who are in the medical intensive care unit (MICU) and have a CVC may be approached to join the study. Those who meet study eligibility and provide written consent will be enrolled. The longer the CVC remains in place,the greater the chance of developing an infection or blood clot. Any IV line that is placed (CVC, midline, peripheral line) comes with the risk of infection or blood clots, although that risk is generally less with the midline and peripheral IV lines than a CVC. The treating team will make the decision when to remove the CVC. The timeline of removal will be compared to previous data collected on patients similar to the ones in this study. During their hospital stay, study patients will be monitored for how well the midline catheter is functioning as well as if they develop a catheter related blood clot or infection.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 16, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 23, 2019

Completed
10 months until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

September 9, 2020

Status Verified

September 1, 2020

Enrollment Period

9 months

First QC Date

October 16, 2019

Last Update Submit

September 3, 2020

Conditions

Keywords

intravenous accessvascular accessIV survivalIV catheter complicationCentral venous accessCentral Line-associated Bloodstream Infection (CLABSI)

Outcome Measures

Primary Outcomes (1)

  • CVC hours

    Number of hours from CVC insertion to CVC removal

    at CVC removal, at any time up to 30 days

Secondary Outcomes (4)

  • CLABSI

    30 days

  • Upper extremity venous thrombosis

    30 days

  • Midline IV catheter survival

    30 days

  • Midline Catheter Associated Phlebitis

    30 days

Study Arms (2)

CVC and Midline Catheter

EXPERIMENTAL

Existing standard of care CVC. Midline catheter placed within 24 hours of CVC placement.

Device: Midline catheter

CVC

NO INTERVENTION

Standard of care CVC: case-matched controls using baseline data.

Interventions

Midline catheter placed in patients with existing standard of care CVC

CVC and Midline Catheter

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients 18 years of age or older admitted to the MICU at Beaumont Hospital- Royal Oak who require a CVC Midline placement by the vascular access team within 24 hours of CVC placement

You may not qualify if:

  • Patients not admitted to MICU
  • Patients \< 18 years of age
  • Patients identified to require a PICC for extended duration of therapy
  • Patients with midline catheters, pre-existing ports, dialysis catheters (Quinton), or other vascular access already inserted within the first 24 hours of CVC insertion (peripheral IV catheters are allowed)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beaumont Hospital - Royal Oak

Royal Oak, Michigan, 48073, United States

Location

MeSH Terms

Conditions

Venous Thrombosis

Condition Hierarchy (Ancestors)

ThrombosisEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Officials

  • Amit Bahl, MD

    Corewell Health East

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Prospective with historical case matched controls, Non-randomized, Single site
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director Emergency Medicine Ultrasound

Study Record Dates

First Submitted

October 16, 2019

First Posted

October 23, 2019

Study Start

September 1, 2020

Primary Completion

June 1, 2021

Study Completion

December 1, 2021

Last Updated

September 9, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations